NDC 0026-3944

Jivi

Antihemophilic Factor (recombinant) Pegylated-aucl

Jivi is a Kit in the Plasma Derivative category. It is labeled and distributed by Bayer Healthcare Llc. The primary component is .

• Product ID: 0026-3944_41013b26-1517-4bc1-9ec0-7ed5e2bd9c6c
• NDC: 0026-3944
• Product Type: Plasma Derivative
• Proprietary Name: Jivi
• Generic Name: Antihemophilic Factor (recombinant) Pegylated-aucl
• Dosage Form: Kit
• Marketing Start Date: 2018-08-30
• Marketing Category: BLA / BLA
• Application Number: BLA125661
• Labeler Name: Bayer HealthCare LLC
• Active Ingredient Strength: 0
• NDC Exclude Flag: N
• Listing Certified Through: 2020-12-31

Packaging

NDC 0026-3944-25

1 KIT in 1 BOX (0026-3944-25) * 2.5 mL in 1 VIAL (0026-4944-99) * 2.5 mL in 1 SYRINGE (0026-0426-02) * 2.5 mL in 1 VIAL, SINGLE-USE (0026-4944-01)

• Marketing Start Date: 2018-08-30
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 0026-3944-99 [00026394499]

Jivi KIT

• Marketing Category: BLA
• Application Number: BLA125661
• Product Type: PLASMA DERIVATIVE
• Marketing Start Date: 2019-03-28

NDC 0026-3944-25 [00026394425]

Jivi KIT

• Marketing Category: BLA
• Application Number: BLA125661
• Product Type: PLASMA DERIVATIVE
• Billing Unit: EA
• Marketing Start Date: 2018-08-30

Drug Details

NDC Crossover Matching brand name "Jivi" or generic name "Antihemophilic Factor (recombinant) Pegylated-aucl"

NDC	Brand Name	Generic Name
0026-3942	Jivi	Antihemophilic Factor (Recombinant) Pegylated-aucl
0026-3944	Jivi	Antihemophilic Factor (Recombinant) Pegylated-aucl
0026-3946	Jivi	Antihemophilic Factor (Recombinant) Pegylated-aucl
0026-3948	Jivi	Antihemophilic Factor (Recombinant) Pegylated-aucl